|
Volumn 202, Issue 5, 2002, Pages 269-271
|
Pancreatic neuroendocrine tumors: How far have we gone ahead?
a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA INTERFERON;
ANGIOPEPTIN;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CHLOROZOTOCIN;
CISPLATIN;
DACARBAZINE;
DIAZOXIDE;
DOXORUBICIN;
ETOPOSIDE;
FLUOROURACIL;
MELPHALAN;
MITOXANTRONE;
NITROSOUREA;
OCTREOTIDE;
OMEPRAZOLE;
PREDNISONE;
RANITIDINE;
SOMATOSTATIN DERIVATIVE;
STREPTOZOCIN;
ARTICLE;
ARTIFICIAL EMBOLISM;
CLINICAL FEATURE;
CONTROLLED STUDY;
GASTROINTESTINAL SYMPTOM;
HORMONE RELEASE;
HUMAN;
INCIDENCE;
LIVER TRANSPLANTATION;
NEUROENDOCRINE TUMOR;
PANCREAS ISLET CELL;
PANCREAS TUMOR;
PANCREAS ISLET CELL CARCINOMA;
PANCREAS ISLET CELL TUMOR;
ADENOMA, ISLET CELL;
CARCINOMA, ISLET CELL;
HUMANS;
PANCREATIC NEOPLASMS;
|
EID: 0035984129
PISSN: 00142565
EISSN: None
Source Type: Journal
DOI: 10.1016/s0014-2565(02)71049-7 Document Type: Article |
Times cited : (1)
|
References (21)
|